|
ATE109793T1
(de)
|
1987-05-22 |
1994-08-15 |
University Patents Inc |
Lineare und zyklische analoge von alpha-msh- fragmenten mit ausserordentlicher wirkung.
|
|
US5674839A
(en)
*
|
1987-05-22 |
1997-10-07 |
Competitive Technologies, Inc. |
Cyclic analogs of alpha-MSH fragments
|
|
US5192746A
(en)
|
1990-07-09 |
1993-03-09 |
Tanabe Seiyaku Co., Ltd. |
Cyclic cell adhesion modulation compounds
|
|
US6100048A
(en)
|
1992-04-10 |
2000-08-08 |
Oregon Health Sciences University |
Methods and reagents for discovering and using mammalian melanocortin receptor agonists and antagonists to modulate feeding behavior in animals
|
|
WO1994022460A1
(en)
|
1993-04-05 |
1994-10-13 |
University Patents, Inc. |
Diagnosis and treatment of erectile dysfunction
|
|
US6054556A
(en)
*
|
1995-04-10 |
2000-04-25 |
The Arizona Board Of Regents On Behalf Of The University Of Arizona |
Melanocortin receptor antagonists and agonists
|
|
US5731408A
(en)
*
|
1995-04-10 |
1998-03-24 |
Arizona Board Of Regents On Behalf Of The University Of Arizona |
Peptides having potent antagonist and agonist bioactivities at melanocortin receptors
|
|
US7396814B2
(en)
*
|
1995-06-07 |
2008-07-08 |
Palatin Technologies, Inc. |
Metallopeptide compositions for treatment of sexual dysfunction
|
|
CA2158425C
(en)
|
1995-09-15 |
2003-01-28 |
Mac E. Hadley |
Diagnostic and treatment of erectile dysfunction
|
|
IL118003A0
(en)
|
1996-04-23 |
1996-08-04 |
Yeda Res & Dev |
Novel vip fragments and pharmaceutical compositions comprising them
|
|
WO1998027113A2
(en)
|
1996-12-17 |
1998-06-25 |
Quadrant Holdings Cambridge Limited |
Melanocortin derivatives for specific binding of melanocortin receptor 3, 4 or 5
|
|
AU7464998A
(en)
*
|
1997-10-27 |
1999-05-17 |
Trega Biosciences, Inc. |
Melanocortin receptor ligands and methods of using same
|
|
US20020099003A1
(en)
*
|
1997-10-28 |
2002-07-25 |
Wilson Leland F. |
Treatment of female sexual dysfunction with vasoactive agents, particularly vasoactive intestinal polypeptide and agonists thereof
|
|
GB9808229D0
(en)
|
1998-04-17 |
1998-06-17 |
Quadrant Holdings Cambridge |
Melanocortin receptor ligands
|
|
SE9801571D0
(sv)
*
|
1998-05-05 |
1998-05-05 |
Wapharm Ab |
Melanokortin-1-receptorselektiva föreningar
|
|
SE9804614A0
(en)
|
1998-07-06 |
2000-01-07 |
A+ Science Invest Ab |
New peptides and use thereof
|
|
GB9816234D0
(en)
|
1998-07-24 |
1998-09-23 |
William Harvey Research Limite |
Compounds for use in the treatment of inflammation
|
|
GB9827500D0
(en)
|
1998-12-14 |
1999-02-10 |
Wapharm Ab |
Compounds for control of eating, growth and body weight
|
|
US6887846B2
(en)
*
|
1999-03-24 |
2005-05-03 |
Zengen, Inc. |
Antimicrobial amino acid sequences derived from alpha-melanocyte-stimulating hormone
|
|
DK1165613T3
(da)
*
|
1999-03-29 |
2008-08-25 |
Procter & Gamble |
Melanocortinreceptorligander
|
|
US6579968B1
(en)
*
|
1999-06-29 |
2003-06-17 |
Palatin Technologies, Inc. |
Compositions and methods for treatment of sexual dysfunction
|
|
US7235625B2
(en)
*
|
1999-06-29 |
2007-06-26 |
Palatin Technologies, Inc. |
Multiple agent therapy for sexual dysfunction
|
|
US7176279B2
(en)
|
2000-06-28 |
2007-02-13 |
Palatin Technologies, Inc. |
Cyclic peptide compositions and methods for treatment of sexual dysfunction
|
|
US6699873B1
(en)
*
|
1999-08-04 |
2004-03-02 |
Millennium Pharmaceuticals, Inc. |
Melanocortin-4 receptor binding compounds and methods of use thereof
|
|
WO2001030808A1
(en)
|
1999-10-27 |
2001-05-03 |
The Regents Of The University Of California |
Methods and compounds for modulating melanocortin receptor-ligand binding
|
|
US20030064921A1
(en)
*
|
1999-10-27 |
2003-04-03 |
The Regents Of The University Of California |
Methods and compounds for modulating melanocortin receptor ligand binding and activity
|
|
AU2001229491A1
(en)
|
2000-01-18 |
2001-07-31 |
Merck And Co., Inc. |
Cyclic peptides as potent and selective melanocortin-4 receptor antagonists
|
|
US6600015B2
(en)
*
|
2000-04-04 |
2003-07-29 |
Hoffmann-La Roche Inc. |
Selective linear peptides with melanocortin-4 receptor (MC4-R) agonist activity
|
|
AU2001261363A1
(en)
|
2000-05-09 |
2001-11-20 |
The Regents Of The University Of California |
Methods and compounds for modulating melanocortin receptor ligand binding and activity
|
|
GB0012370D0
(en)
|
2000-05-22 |
2000-07-12 |
Quadrant Holdings Cambridge |
Peptoids
|
|
CZ2003584A3
(cs)
*
|
2000-08-30 |
2003-08-13 |
F. Hoffmann-La Roche Ag |
Selektivní cyklické peptidy
|
|
RU2246501C2
(ru)
|
2000-09-27 |
2005-02-20 |
Дзе Проктер Энд Гэмбл Компани |
Лиганды меланокортиновых рецепторов
|
|
US20030113263A1
(en)
*
|
2001-02-13 |
2003-06-19 |
Oregon Health And Sciences University, A Non-Profit Organization |
Methods and reagents for using mammalian melanocortin receptor antagonists to treat cachexia
|
|
ITMI20011057A1
(it)
|
2001-05-22 |
2002-11-22 |
Bracco Imaging Spa |
Preparazione ed uso di peptidi ciclici e ramificati e loro deriati marcati come agenti terapeutici agonisti o antagonisti della colecistochi
|
|
US7345144B2
(en)
*
|
2001-07-11 |
2008-03-18 |
Palatin Technologies, Inc. |
Cyclic peptides for treatment of cachexia
|
|
US7342089B2
(en)
|
2001-07-11 |
2008-03-11 |
Palatin Technologies, Inc. |
Cyclic peptides for treatment for cachexia
|
|
AU2002322466B2
(en)
|
2001-07-11 |
2007-08-30 |
Palatin Technologies, Inc. |
Linear and cyclic melanocortin receptor-specific peptides
|
|
EP1409521A2
(en)
|
2001-07-12 |
2004-04-21 |
Merck & Co., Inc. |
Cyclic peptides as potent and selective melanocortin-4 receptor agonists
|
|
WO2003061660A1
(en)
*
|
2002-01-23 |
2003-07-31 |
Eli Lilly And Company |
Melanocortin receptor agonists
|
|
FR2835528B1
(fr)
*
|
2002-02-01 |
2004-03-12 |
Inst Europ Biolog Cellulaire |
Nouveaux derives peptidiques, leur preparation et leur application therapeutique et cosmetique
|
|
US7034004B2
(en)
*
|
2002-05-07 |
2006-04-25 |
University Of Florida |
Peptides and methods for the control of obesity
|
|
WO2004005324A2
(en)
|
2002-07-09 |
2004-01-15 |
Palatin Technologies, Inc. |
Peptide composition for treatment of sexual dysfunction
|
|
US7135548B2
(en)
*
|
2002-11-14 |
2006-11-14 |
Zengen, Inc. |
Modified α-MSH peptides and derivatives thereof
|
|
AU2003290886A1
(en)
|
2002-11-14 |
2004-06-15 |
Zengen, Inc. |
Modified alpha-msh peptides and derivatives thereof
|
|
US20050101535A1
(en)
*
|
2003-05-06 |
2005-05-12 |
Rosenstein David H. |
Use of a synthetic alpha-melanocyte stimulating hormone agonist to decrease steroid induced weight gain
|
|
BRPI0409976A
(pt)
|
2003-05-09 |
2006-05-09 |
Novo Nordisk As |
composto, métodos para retardar a progressão de igt diabetes do tipo 2, para retardar a progressão de diabetes do tipo 2 para diabetes que requer insulina, para tratar obesidade ou prevenir excesso de peso para regular o apetite para induzir saciedade, para prevenir ganho de peso após se ter tido sucesso em perder peso, para aumentar dispêndio de energia, para tratar uma doença ou estado e para tratar bulimia, composição farmacêutica, e, uso de um composto
|
|
KR20060026011A
(ko)
*
|
2003-05-09 |
2006-03-22 |
노보 노르디스크 에이/에스 |
비만 치료용 펩티드
|
|
WO2005000338A1
(en)
|
2003-06-19 |
2005-01-06 |
Eli Lilly And Company |
Uses of melanocortin-3 receptor (mc3r) agonist peptides
|
|
CA2530024A1
(en)
*
|
2003-06-19 |
2005-01-06 |
Eli Lilly And Company |
Melanocortin receptor 4(mc4) agonists and their uses
|
|
US7084111B2
(en)
|
2003-06-23 |
2006-08-01 |
University Of Florida Research Foundation, Inc. |
Melanocortin receptor templates, peptides, and use thereof
|
|
ATE361294T1
(de)
|
2003-08-20 |
2007-05-15 |
Lilly Co Eli |
Verbindungen, verfahren und formulierungen zur oralen verabreichung einer glucagonartigen peptid (glp)-1-verbindung oder eines melanocortin-4- rezeptor-(mc4-)agonistschen peptids
|
|
EP1670815A2
(en)
|
2003-09-30 |
2006-06-21 |
Novo Nordisk A/S |
Melanocortin receptor agonists
|
|
EP1689349B9
(en)
|
2003-11-24 |
2014-02-26 |
Clinuvel Pharmaceuticals Limited |
A method of inducing melanogenesis in humans with mc1r variant alleles
|
|
US20070155660A1
(en)
|
2003-12-10 |
2007-07-05 |
Marsh Donald J |
Inhibition of voluntary ethanol consumption with selective melanocortin 4-receptor agonists
|
|
US20070123453A1
(en)
*
|
2004-03-29 |
2007-05-31 |
Heiman Mark L |
Uses of melanocortin-4 receptor (mc4r) agonist peptides administered by continuous infusion
|
|
CN1563076A
(zh)
|
2004-04-02 |
2005-01-12 |
西南生物工程产业化中试基地有限公司 |
一种用于治疗性功能障碍的α－MSH类似物及制备方法
|
|
AU2005269244B2
(en)
|
2004-08-04 |
2010-12-09 |
Clinuvel Pharmaceuticals Limited |
Methods of inducing melanogenesis in a subject.
|
|
TW200626611A
(en)
|
2004-09-20 |
2006-08-01 |
Lonza Ag |
Peptide cyclisation
|
|
EP1812034A4
(en)
|
2004-10-08 |
2009-07-29 |
Clinuvel Pharmaceuticals Ltd |
COMPOSITIONS AND METHODS OF INDUCING MELANOESEES IN ONE PERSON
|
|
ME01234B
(me)
*
|
2004-10-25 |
2013-06-20 |
Centocor Inc |
Mimetička tijela koja vezuju receptore melanokortina, smjese, postupci i upotrebe
|
|
EP1809666A2
(en)
|
2004-11-04 |
2007-07-25 |
Novo Nordisk A/S |
Peptides for use in the treating obesity
|
|
JP2008519009A
(ja)
|
2004-11-04 |
2008-06-05 |
ノボ ノルディスク アクティーゼルスカブ |
肥満症の治療に使用するためのペプチド
|
|
JP2008519008A
(ja)
|
2004-11-04 |
2008-06-05 |
ノボ ノルディスク アクティーゼルスカブ |
肥満症の治療に使用するためのペプチド
|
|
EP1809665A2
(en)
*
|
2004-11-04 |
2007-07-25 |
Novo Nordisk A/S |
Mc4r selective peptides and their use in the treatment of obesity
|
|
WO2006060873A1
(en)
|
2004-12-09 |
2006-06-15 |
Prince Henry's Institute Of Medical Research |
Method for restoring reproductive function
|
|
WO2006073771A2
(en)
|
2005-01-05 |
2006-07-13 |
Eli Lilly And Company |
Polyethylene glycol linked mc4r or mc3r agonist peptides
|
|
US7563781B2
(en)
|
2005-01-14 |
2009-07-21 |
Janssen Pharmaceutica Nv |
Triazolopyrimidine derivatives
|
|
US20080207493A1
(en)
|
2005-03-17 |
2008-08-28 |
Novo Nordisk A/S |
Compounds for Use in the Treatment of Obesity
|
|
CN101203527A
(zh)
|
2005-05-31 |
2008-06-18 |
耶路撒冷希伯来大学伊森姆研究发展公司 |
主链环化的促黑皮质素激素（αMSH）类似物
|
|
JP2009500426A
(ja)
|
2005-07-08 |
2009-01-08 |
ソシエテ・ドゥ・コンセイユ・ドゥ・ルシェルシュ・エ・ダプリカーション・シャンティフィック・エス・ア・エス |
メラノコルチン受容体のリガンド
|
|
PL2286825T3
(pl)
|
2005-07-08 |
2017-06-30 |
Ipsen Pharma |
Ligandy receptora melanokortyny
|
|
CN1709906A
(zh)
|
2005-07-15 |
2005-12-21 |
中国科学技术大学 |
α－促黑激素的环状类似肽及其应用
|
|
AU2006271792A1
(en)
|
2005-07-18 |
2007-01-25 |
Novo Nordisk A/S |
Peptides for use in the treatment of obesity
|
|
US20080227693A1
(en)
|
2005-08-29 |
2008-09-18 |
Palatin Technologies, Inc. |
Cyclic Peptide Isolation by Spray Drying
|
|
WO2007035474A2
(en)
|
2005-09-15 |
2007-03-29 |
Novomed Technologies, Inc. (Shanghai) |
Transdermal delivery peptides and method of use thereof
|
|
WO2008056207A1
(en)
|
2006-11-08 |
2008-05-15 |
Chongxi Yu |
Transdermal delivery systems of peptides and related compounds
|
|
WO2008087190A2
(en)
|
2007-01-18 |
2008-07-24 |
Novo Nordisk A/S |
Use of peptides in combination with surgical intervention for the treatment of obesity
|
|
WO2008087187A1
(en)
|
2007-01-18 |
2008-07-24 |
Novo Nordisk A/S |
Peptides for use in the treatment of obesity
|
|
WO2008087188A2
(en)
|
2007-01-18 |
2008-07-24 |
Novo Nordisk A/S |
Peptides for use in the treatment of obesity
|
|
EP2106405A2
(en)
|
2007-01-18 |
2009-10-07 |
Novo Nordisk A/S |
Peptides for use in the treatment of obesity
|
|
JP2010516654A
(ja)
|
2007-01-18 |
2010-05-20 |
ノボ・ノルデイスク・エー／エス |
肥満の治療に使用される新規ペプチド
|
|
FR2914646A1
(fr)
|
2007-04-04 |
2008-10-10 |
Neorphys Soc Par Actions Simpl |
Analogues peptidiques des recepteurs des melanocortines
|
|
AR066175A1
(es)
|
2007-06-15 |
2009-08-05 |
Sod Conseils Rech Applic |
Ligandos del receptor de melanocortina de peptidos ciclicos
|
|
TW201002340A
(en)
*
|
2008-06-09 |
2010-01-16 |
Palatin Technologies Inc |
Melanocortin receptor-specific peptides for treatment of obesity
|
|
KR101687037B1
(ko)
*
|
2008-06-09 |
2016-12-15 |
팔라틴 테크놀로지스 인코포레이티드 |
성기능 장애 치료용 멜라노코르틴 수용체-특이적 펩티드
|
|
UY32690A
(es)
*
|
2009-06-08 |
2011-01-31 |
Astrazeneca Ab |
Péptidos específicos para receptores de melanocortina
|
|
WO2010144341A2
(en)
|
2009-06-08 |
2010-12-16 |
Palatin Technologies, Inc. |
Lactam-bridged melanocortin receptor-specific peptides
|